BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37219049)

  • 1. Toxicity and efficacy of green tea catechin derivative-based micellar nanocomplexes for anticancer protein delivery.
    Xiong S; Tan S; Huang P; Li Y; Chung JE; Kurisawa M; Zink D; Ying JY
    Biomater Sci; 2023 Jun; 11(13):4675-4683. PubMed ID: 37219049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly Augmented Drug Loading and Stability of Micellar Nanocomplexes Composed of Doxorubicin and Poly(ethylene glycol)-Green Tea Catechin Conjugate for Cancer Therapy.
    Liang K; Chung JE; Gao SJ; Yongvongsoontorn N; Kurisawa M
    Adv Mater; 2018 Apr; 30(14):e1706963. PubMed ID: 29473233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-assembled micellar nanocomplexes comprising green tea catechin derivatives and protein drugs for cancer therapy.
    Chung JE; Tan S; Gao SJ; Yongvongsoontorn N; Kim SH; Lee JH; Choi HS; Yano H; Zhuo L; Kurisawa M; Ying JY
    Nat Nanotechnol; 2014 Nov; 9(11):907-912. PubMed ID: 25282044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid-green tea catechin micellar nanocomplexes: Fail-safe cisplatin nanomedicine for the treatment of ovarian cancer without off-target toxicity.
    Bae KH; Tan S; Yamashita A; Ang WX; Gao SJ; Wang S; Chung JE; Kurisawa M
    Biomaterials; 2017 Dec; 148():41-53. PubMed ID: 28961534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carrier-Enhanced Anticancer Efficacy of Sunitinib-Loaded Green Tea-Based Micellar Nanocomplex beyond Tumor-Targeted Delivery.
    Yongvongsoontorn N; Chung JE; Gao SJ; Bae KH; Yamashita A; Tan MH; Ying JY; Kurisawa M
    ACS Nano; 2019 Jul; 13(7):7591-7602. PubMed ID: 31262169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The vitamin E analog, alpha-tocopheryloxyacetic acid enhances the anti-tumor activity of trastuzumab against HER2/neu-expressing breast cancer.
    Hahn T; Bradley-Dunlop DJ; Hurley LH; Von-Hoff D; Gately S; Mary DL; Lu H; Penichet ML; Besselsen DG; Cole BB; Meeuwsen T; Walker E; Akporiaye ET
    BMC Cancer; 2011 Nov; 11():471. PubMed ID: 22044845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer compounds.
    Fujiki H; Sueoka E; Watanabe T; Suganuma M
    J Cancer Res Clin Oncol; 2015 Sep; 141(9):1511-22. PubMed ID: 25544670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Green Tea Catechin-Based Complex Micelles Combined with Doxorubicin to Overcome Cardiotoxicity and Multidrug Resistance.
    Cheng T; Liu J; Ren J; Huang F; Ou H; Ding Y; Zhang Y; Ma R; An Y; Liu J; Shi L
    Theranostics; 2016; 6(9):1277-92. PubMed ID: 27375779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
    Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
    Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of a novel prodrug of green tea extract in induction of apoptosis via ERK/JNK and Akt signaling pathway in human endometrial cancer.
    Man GCW; Wang J; Song Y; Wong JH; Zhao Y; Lau TS; Leung KT; Chan TH; Wang H; Kwong J; Ng TB; Wang CC
    BMC Cancer; 2020 Oct; 20(1):964. PubMed ID: 33023525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Green tea catechins: a fresh flavor to anticancer therapy.
    Yu Y; Deng Y; Lu BM; Liu YX; Li J; Bao JK
    Apoptosis; 2014 Jan; 19(1):1-18. PubMed ID: 24081390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Green Tea Catechin Is an Alternative Immune Checkpoint Inhibitor that Inhibits PD-L1 Expression and Lung Tumor Growth.
    Rawangkan A; Wongsirisin P; Namiki K; Iida K; Kobayashi Y; Shimizu Y; Fujiki H; Suganuma M
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30126206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herceptin-conjugated paclitaxel loaded PCL-PEG worm-like nanocrystal micelles for the combinatorial treatment of HER2-positive breast cancer.
    Peng J; Chen J; Xie F; Bao W; Xu H; Wang H; Xu Y; Du Z
    Biomaterials; 2019 Nov; 222():119420. PubMed ID: 31445322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New cancer treatment strategy using combination of green tea catechins and anticancer drugs.
    Suganuma M; Saha A; Fujiki H
    Cancer Sci; 2011 Feb; 102(2):317-23. PubMed ID: 21199169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trastuzumab-resistant HER2-driven breast cancer cells are sensitive to epigallocatechin-3 gallate.
    Eddy SF; Kane SE; Sonenshein GE
    Cancer Res; 2007 Oct; 67(19):9018-23. PubMed ID: 17909003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of catechin extracts and nanoemulsions from green tea leaf waste and their inhibition effect on prostate cancer cell PC-3.
    Tsai YJ; Chen BH
    Int J Nanomedicine; 2016; 11():1907-26. PubMed ID: 27226712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow-targetable Green Tea Catechin-Based Micellar Nanocomplex for synergistic therapy of Acute myeloid leukemia.
    Bae KH; Lai F; Mong J; Niibori-Nambu A; Chan KH; Her Z; Osato M; Tan MH; Chen Q; Kurisawa M
    J Nanobiotechnology; 2022 Nov; 20(1):481. PubMed ID: 36384529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Green tea and its catechins inhibit breast cancer xenografts.
    Sartippour MR; Heber D; Ma J; Lu Q; Go VL; Nguyen M
    Nutr Cancer; 2001; 40(2):149-56. PubMed ID: 11962250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies on the effects of green tea extracts and individual tea catechins on human CYP1A gene expression.
    Williams SN; Shih H; Guenette DK; Brackney W; Denison MS; Pickwell GV; Quattrochi LC
    Chem Biol Interact; 2000 Nov; 128(3):211-29. PubMed ID: 11064004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The co-delivery of paclitaxel and Herceptin using cationic micellar nanoparticles.
    Lee AL; Wang Y; Cheng HY; Pervaiz S; Yang YY
    Biomaterials; 2009 Feb; 30(5):919-27. PubMed ID: 19042015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.